Shire PLC has teamed up with robotic pill specialist Rani Therapeutics LLC to investigate an oral option for hemophilia patients that could transform the treatment pathway for sufferers of the bleeding disorder and replace injections.
The collaboration will involve research on the use of the Rani Pill technology for the oral delivery of Factor VIII...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?